"This is about starting the data story at the source," said Charles Hutka, Chief Commercial Officer at StafaCT. "When apheresis data is captured directly -- across both collection and therapeutic ...
Dublin, Feb. 10, 2020 (GLOBE NEWSWIRE) -- The "Apheresis Market by Product [Device (Centrifugation, Membrane Separation) Disposable], Procedure (Donor, Therapeutic ...
DUBLIN--(BUSINESS WIRE)--The "Apheresis Equipment - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive ...
May 23 (UPI) --A new treatment might be able to remove "bad cholesterol" from the blood in a matter of hours, a recent study says. Within two to three hours, a procedure known as LDL apheresis drove ...
ENGLEWOOD, Colo., Aug. 15, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...
Significant advances have been made over the last 20 years in long-term immunomodulatory therapy of multiple sclerosis. However, the same cannot be said for the treatment of acute relapses, explain ...
(MENAFN- EIN Presswire) EINPresswire/ -- The global therapeutic apheresis market is projected to grow from US$3.2 billion in 2026 to US$3.9 billion by 2033, at a CAGR of 2.7%. Therapeutic apheresis ...
Rising Prevalence of Chronic Diseases and Growing Number of Trauma and Injury Cases. Increasing Demand for Source Plasma From Biopharmaceutical Companies. Rising Demand for Blood Components and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results